cas 1672663-10-3|| where to buy 4-Fluoro-7-(methylthio)-2,3-dihydro-1H-inden-1-one

Nom du produit:4-Fluoro-7-(methylthio)-2,3-dihydro-1H-inden-1-one

IUPAC Name:4-fluoro-7-(methylsulfanyl)-2,3-dihydro-1H-inden-1-one

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM290140-1g	in stock	țǧǊȁ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1672663-10-3 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1672663-10-3; Formule moléculaire:C10H9FOS; Point de fusion:-; Code SMILES:O=C1CCC2=C1C(SC)=CC=C2F; Densité:

: Numéro de catalogue:CM290140; Poids moléculaire:196.24; Point d'ébullition:; N° Mdl:; Stockage:

: Indenes; Indenes are useful building blocks found in a variety of biologically relevant products.

: Belzutifan; On September 19, MSD announced that the U.S. FDA has accepted and granted priority review for a supplemental new drug application (sNDA) seeking approval for Welireg (Belzutifan), Merck's oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor, for the treatment of adult patients with advanced renal cell carcinoma (RCC). Welireg was the first HIF-2α inhibitor therapy approved in the U.S. and is currently approved for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated RCC, central nervous system hemangioblastomas, or pancreatic neuroendocrine tumors, not requiring immediate surgery.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.